LIFE - aTyr Pharma Inc. (LIFE) CEO Dr. Sanjay S. Shukla on Q1 2022 Results - Earnings Call Transcript

aTyr Pharma, Inc. (LIFE) Q1 2022 Earnings Conference Call May 9, 2022, 5:00 PM ET Company Participants Dr. Sanjay S. Shukla – President and Chief Executive Officer Jill Broadfoot – Chief Financial Officer Ashlee Dunston – Director, Investor Relations and Corporate Communications Conference Call Participants Hartaj Singh – Oppenheimer & Company Zegbeh Jallah – ROTH Capital Partners Yale Jen – Laidlaw & Company Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma First Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode. Later, we'll conduct a question and answer, and instructions will be given the time. As a reminder, this conference is being recorded for replay purposes. It is now my pleasure to hand the conference call over to Ashlee Dunston, a Tyr's Director of Investor Relations and Corporate Communications. Ms. Dunston, you may begin. Ashlee Dunston Thank you, Operator. And

For further details see:

aTyr Pharma, Inc. (LIFE) CEO Dr. Sanjay S. Shukla on Q1 2022 Results - Earnings Call Transcript